ATE111736T1 - Okulare hypotensive mittel. - Google Patents

Okulare hypotensive mittel.

Info

Publication number
ATE111736T1
ATE111736T1 AT89310016T AT89310016T ATE111736T1 AT E111736 T1 ATE111736 T1 AT E111736T1 AT 89310016 T AT89310016 T AT 89310016T AT 89310016 T AT89310016 T AT 89310016T AT E111736 T1 ATE111736 T1 AT E111736T1
Authority
AT
Austria
Prior art keywords
ocular hypotensive
remedies
ocular
composition
hypotensive
Prior art date
Application number
AT89310016T
Other languages
German (de)
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Tomio Oda
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP24872188A external-priority patent/JPH0739344B2/ja
Priority claimed from JP24872088A external-priority patent/JPH0739343B2/ja
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE111736T1 publication Critical patent/ATE111736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Endoscopes (AREA)
AT89310016T 1988-10-01 1989-09-29 Okulare hypotensive mittel. ATE111736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24872188A JPH0739344B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤
JP24872088A JPH0739343B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤

Publications (1)

Publication Number Publication Date
ATE111736T1 true ATE111736T1 (de) 1994-10-15

Family

ID=26538919

Family Applications (2)

Application Number Title Priority Date Filing Date
AT89310016T ATE111736T1 (de) 1988-10-01 1989-09-29 Okulare hypotensive mittel.
AT93202691T ATE162074T1 (de) 1988-10-01 1989-09-29 Oculare hypotensive mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT93202691T ATE162074T1 (de) 1988-10-01 1989-09-29 Oculare hypotensive mittel

Country Status (3)

Country Link
EP (2) EP0580268B1 (enExample)
AT (2) ATE111736T1 (enExample)
DE (2) DE68918391T2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1300149A3 (en) * 1988-09-06 2003-05-14 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE420857T1 (de) * 1988-09-06 2009-01-15 Pfizer Health Ab Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
ES2067864T3 (es) * 1990-05-22 1995-04-01 R Tech Ueno Ltd Tratamiento de la hipertension ocular con una combinacion sinergica para administracion ocular.
US5166175A (en) * 1990-05-22 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination
DE69106777T2 (de) * 1990-05-22 1995-05-18 Ueno Seiyaku Oyo Kenkyujo Kk Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
TW210287B (enExample) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
WO1998020881A1 (en) * 1996-11-12 1998-05-22 Alcon Laboratories, Inc 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
SE9900672D0 (sv) 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
JP2004538306A (ja) * 2001-07-31 2004-12-24 スキャンポ・アーゲー 高眼圧症および緑内障の処置
EP1420793A1 (en) * 2001-08-23 2004-05-26 Sucampo AG Method and composition for treatment of ocular hypertension and glaucoma
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356581A (en) * 1970-10-09 1974-06-12 Ici Ltd Cyclopentane derivatives
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
JPH0762626B2 (ja) * 1987-06-23 1995-07-05 株式会社大洋バルブ製作所 流量検出器
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化

Also Published As

Publication number Publication date
EP0580268A3 (enExample) 1994-02-23
EP0366279A3 (en) 1991-12-27
ATE162074T1 (de) 1998-01-15
EP0366279B1 (en) 1994-09-21
EP0366279A2 (en) 1990-05-02
DE68928551T2 (de) 1998-04-23
DE68918391D1 (de) 1994-10-27
DE68918391T2 (de) 1995-01-19
DE68928551D1 (de) 1998-02-19
EP0580268A2 (en) 1994-01-26
EP0580268B1 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
ATE111736T1 (de) Okulare hypotensive mittel.
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
EP0045617A3 (en) Pharmaceutical composition
EP1110554A4 (en) MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
CA2234247A1 (en) An agent for curing ophthalmological diseases
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
ATE109001T1 (de) Mittel zur stimulierung der tränensekretion.
DE69430521D1 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension
FI962976L (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
DE69825981D1 (de) 4,5-dihydroxy-2-cyclopenten-1-on für die Behandlung von Diabetes Mellitus
ES2171742T3 (es) Agente reductor de la presion ocular.
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
EP1300150A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties